![Jay Kranzler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Kranzler
Président chez
AVENUE THERAPEUTICS, INC.
Fortune : 170 $ au 30/06/2026
Profil
Jay D.
Kranzler was the founder of Sequel Therapeutics, Inc., founded in 1992, where the title held was President & Chief Executive Officer.
Dr. Kranzler was the founder of Glytec Corp., founded in 1989, where the title held was President & Chief Executive Officer in 1990.
Dr. Kranzler was also the founder of Perception Neuroscience, Inc...
Dr. Kranzler was previously Chairman & Chief Executive Officer at Urica Therapeutics, Inc. since 2022.
Dr. Kranzler is Chief Executive Officer & Director at Regenovation, Inc. Dr. Kranzler is Chairman at Avenue Therapeutics, Inc. since 2023.
Dr. Kranzler is Director at Navitas Pharma, Inc. Dr. Kranzler is Director at ImmunoBrain Checkpoint Ltd. Dr. Kranzler is Chief Medical Officer & Director at Pastorus, Inc. Dr. Kranzler is Director at Baergic Bio, Inc. Former positions include Chairman & Chief Executive Officer at Cypress Bioscience, Inc. from 1996 to 2011.
Dr. Kranzler was President, Chief Executive Officer & Director at Cytel Corp.
from 1989 to 1995.
Dr. Kranzler was Chairman at MSI Methylation Sciences, Inc. Dr. Kranzler was Vice President & Head-External R&D Innovation at Pfizer Inc. Dr. Kranzler was Professor at the University of California San Diego.
Education includes a doctorate from Yale University and an undergraduate degree from Yeshiva University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/11/2025 | 559 ( 0,02 % ) | 170 $ | 30/06/2026 |
Postes actifs de Jay Kranzler
| Sociétés | Poste | Début |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Président | 07/03/2023 |
Urica Therapeutics, Inc. | Directeur Général | 01/10/2022 |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Directeur/Membre du Conseil | - |
Pastorus, Inc.
 Pastorus, Inc. Pharmaceuticals: GenericHealth Technology Manufactures drugs | Directeur Technique/Scientifique/R&D | - |
ImmunoBrain Checkpoint Ltd.
 ImmunoBrain Checkpoint Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company transforming the fight against neurodegeneration and aging by targeting the immune systems | Directeur/Membre du Conseil | - |
Regenovation, Inc.
 Regenovation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company | Directeur Général | - |
Navitas Pharma, Inc.
 Navitas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Directeur/Membre du Conseil | - |
Anciens postes connus de Jay Kranzler
| Sociétés | Poste | Fin |
|---|---|---|
MSI Methylation Sciences, Inc.
 MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Président | - |
Cypress Bioscience, Inc.
 Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Directeur Général | 01/02/2011 |
| ░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Jay Kranzler
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Cypress Bioscience, Inc.
Cypress Bioscience, Inc. BiotechnologyHealth Technology Develops drugs, diagnostics and other therapeutic products | Health Technology |
Navitas Pharma, Inc.
Navitas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
MSI Methylation Sciences, Inc.
MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products through compound leverage | Health Technology |
Sequel Therapeutics, Inc.
 Sequel Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapeutic vaccines | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yeshiva University
 Yeshiva University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cytel Corp. | |
Glytec Corp. | |
Regenovation, Inc.
Regenovation, Inc. Miscellaneous Commercial ServicesCommercial Services Operates biotechnology company | Commercial Services |
Avenue Therapeutics, Inc.
 Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
ImmunoBrain Checkpoint Ltd.
ImmunoBrain Checkpoint Ltd. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company transforming the fight against neurodegeneration and aging by targeting the immune systems | Health Technology |
Perception Neuroscience, Inc.
 Perception Neuroscience, Inc. Medical/Nursing ServicesHealth Services Develops therapies in neuropsychiatry industry | Health Services |
Pastorus, Inc.
Pastorus, Inc. Pharmaceuticals: GenericHealth Technology Manufactures drugs | Health Technology |
Baergic Bio, Inc.
Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs for treatment of central nervous system disorders | Health Technology |
Urica Therapeutics, Inc. |
